Phase i/ii clinical trial of the humanized anti-egf-r monoclonal antibody h-r3 labelled with ^99mtc in patients with tumour of epithelial origin

Article

Abstract: To evaluate the biodistribution, internal radiation dosimetry and toxicity of the humanized MAb h-R3

Palabras claves:

biodistribution, Dosimetry, Humanized MAb, Radioimmunodiagnosis

Autores:

Aguilar V., Batista J.F., Coca M.A., Hernández A., Iznaga-Escobar N., Neninger Vinageras E., Perera A., Pérez M., Ramos M., Romero S., Sánchez E., Tania Crombet, Torres L.

Fuentes:

scopus